C07K 14/4721
Lipocortins
Official title: {Lipocortins}
C07K14/4721 (Lipocortins) appears on 122 US grants and 133 published applications in this corpus.
Search patents in C07K- Granted patents
- 122
- Published applications
- 133
- Assignees
- 104
- Inventors
- 278
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 0 |
| 2002 | 5 | 12 |
| 2003 | 7 | 11 |
| 2004 | 2 | 5 |
| 2005 | 3 | 8 |
| 2006 | 3 | 10 |
| 2007 | 2 | 3 |
| 2008 | 3 | 3 |
| 2009 | 4 | 9 |
| 2010 | 5 | 5 |
| 2011 | 3 | 3 |
| 2012 | 1 | 5 |
| 2013 | 3 | 8 |
| 2014 | 2 | 3 |
| 2015 | 4 | 5 |
| 2016 | 3 | 1 |
| 2017 | 2 | 3 |
| 2018 | 3 | 8 |
| 2019 | 4 | 5 |
| 2020 | 4 | 4 |
| 2021 | 0 | 7 |
| 2022 | 4 | 1 |
| 2023 | 3 | 6 |
| 2024 | 1 | 4 |
| 2025 | 1 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising annexin V and HPV tumor antigen fusion polypeptides and methods for making and use9 Jun 2026US 12,649,767 B2The Johns Hopkins University
- Targeting anabolic drugs for accelerated fracture repair3 Jun 2025US 12,319,721 B2Purdue Research Foundation
- Compositions and methods for enhancing an immune response21 May 2024US 11,987,606 B2The Johns Hopkins University
- Process of manufacture of annexin V3 Oct 2023US 11,773,134 B2Annexin Pharmaceuticals AB
- Methods for enhancing antigen-specific immune responses26 Sep 2023US 11,766,478 B2The Johns Hopkins University
- Targeting anabolic drugs for accelerated fracture repair8 Jan 2026US 2026/0008829 A1Purdue Research Foundation
- Annexin a1-derived polypeptide analogues25 Dec 2025US 2025/0388632 A1
- Marker for use in identifying or predicting angiogenesis27 Nov 2025US 2025/0360231 A1
- Neuroprotection and Axon Regeneration Therapies for CNS Axonopathies by Modulating Membrane Structure, Cytoskeleton and Signaling Molecules31 Jul 2025US 2025/0242055 A1
- Mutated annexin a5 polypeptides and uses thereof for therapeutic purposes2 May 2024US 2024/0141001 A1Institut National de la Sante et de la Recherche Medicale
Most cited
By later US patents
- Methods for producing hybrid phospholipid-binding proteins62US 5,225,537 AZymoGenetics, Inc. · 1993
- Phospholipid-targeted thrombolytic agents54US 5,632,986 AUniversity of Washington · 1997
- Mammaglobin antigens33US 5,922,836 AWashington University · 1999
- Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity31US 4,937,324 AThe Board of Regents of the University of Washington · 1990
- Use of an anticoagulant as a diagnostic agent30US 5,627,036 ABoehringer Ingelheim International GmbH · 1997